VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Recruiting · NCT06570889 · Interventional (participants receive a specific treatment) · Lead sponsor: Professor Klaus Bønnelykke
View the official record on ClinicalTrials.gov →Interventions studied
Cholecalciferol D3Olive oil
What this trial is about
The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.
Who can take part
Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Eligibility criteria (as published)
* Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids
* No current vitamin D intake above the recommended 400 IU/day
* No endocrine-, heart-, kidney- or auto-immune disorders
* No disorders requiring treatment with blood thinning medication
Where it is running
2 locations listed.
- Copenhagen University Hospital of Copenhagen - Gentofte Municipality, Denmark
- Copenhagen University Hospital of Copenhagen - Gentofte Municipality, Denmark